Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for perimenopausal uterine fibroids (Phase II, CTR20131551)
CTR20131551Phase 2Active
- Sponsor
- Hubei Gedian Humanwell Pharmaceutical
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in Fibromyoma (LM), sponsored by Hubei Gedian Humanwell Pharmaceutical. Started Jan 2014; status: active.
02
Drugs
mifepristone
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on CTR20131551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131551.